The purpose of this research is to determine if treating appendicitis with antibiotics is as effective as surgery in children. The study will monitor children for one year after treatment. During treatment, patients receiving antibiotics will first get the medication through a vein for up to two days, followed by oral medication that can be taken at home.

If antibiotics are not effective, cefoxitin may be used as an alternative medication. The study will track how well each treatment works and any problems that might occur. This includes checking if patients need additional treatment, develop infections, or experience any unwanted effects from either the antibiotics or surgery.

The purpose of the study is to determine whether antibiotics can successfully treat acute uncomplicated appendicitis without the need for surgery. Participants in the study will be randomly assigned to receive either the antibiotics or a placebo. The study is designed to be double-blind, meaning neither the participants nor the researchers will know who is receiving the antibiotics and who is receiving the placebo. This helps ensure that the results are not influenced by expectations about the treatment.

Throughout the study, participants will be monitored to see if the treatment successfully resolves the appendicitis, allowing them to be discharged from the hospital without needing surgery. The study will also track any complications, the length of hospital stays, and the overall quality of life of participants over time. Follow-up evaluations will occur at various intervals, including one, three, five, and ten years after treatment, to assess any long-term effects or recurrence of appendicitis.

The purpose of the study is to evaluate how well these treatments work in managing appendicitis without the need for surgery, as well as to assess the cost-effectiveness of this approach. Participants in the study will receive treatment for a total of 10 days, with 3 days of in-patient care followed by 7 days of out-patient care. The study will also include follow-up checks at one month and one year to monitor the long-term outcomes of the treatment.

This trial is designed to provide new insights into early diagnosis and treatment options for children with appendicitis, potentially offering a less invasive alternative to surgery. By participating in this study, researchers hope to establish new criteria for diagnosing and treating this condition effectively and economically.

The purpose of the study is to evaluate whether this antibiotic wash can lower the chances of getting an abscess by at least 50%. Participants in the study will undergo the standard surgical procedure to remove the appendix, known as a laparoscopic appendectomy, and then receive the antibiotic wash. The study will monitor participants for 30 days after the surgery to check for any signs of an abscess. Additionally, other aspects such as wound infections, the need for further treatment, and overall recovery will be observed for up to 90 days.

This trial is designed to gather information on the effectiveness and safety of using antibiotics in this way. By participating, researchers hope to find a better way to prevent complications after surgery for those with complicated appendicitis. The study is expected to continue until 2027, with recruitment starting in 2025.

The purpose of the study is to examine how well Ketorolac works in managing pain and other clinical and biochemical factors in children with uncomplicated acute appendicitis who are receiving non-surgical treatment. The study aims to develop a pain management plan based on the findings. Participants will receive the treatment and be monitored for their pain levels and other health indicators over a period of three days.

During the study, some participants may receive a placebo, which is a substance with no active medication, to compare the effects of Ketorolac. The study will help researchers understand the effectiveness of Ketorolac in treating pain associated with uncomplicated acute appendicitis in children, potentially leading to better pain management strategies in the future.

Participants in the study will receive one of several antimicrobial treatments. These treatments include levofloxacin, which is taken as a tablet, ertapenem, which is given as a solution for infusion, metronidazole, which is also taken as a tablet, and moxifloxacin, which is provided as a film-coated tablet. These medications are used to help fight infections and are part of the study to see how they impact the gut microbiota.

The study will follow participants over a period of time to observe changes in the gut microbiota and to determine if there is any connection between these changes and the severity of appendicitis. Participants will be monitored for the duration of their treatment, which varies depending on the medication, and the effects on their gut bacteria will be evaluated. The study aims to provide insights into the relationship between antimicrobial treatments and gut health in patients with acute appendicitis.

The antibiotics being studied in this trial include Levofloxacin, Ertapenem, Moxifloxacin, and Metronidazole. Levofloxacin and Moxifloxacin are taken as tablets, while Ertapenem is given as a solution through an infusion, which is a method of delivering medication directly into the bloodstream. Metronidazole is also taken as a tablet. These medications are all antimicrobial agents, which means they are used to treat infections caused by bacteria.

The purpose of the study is to determine if oral antibiotic treatment alone is as effective as the combination of intravenous and oral antibiotics in treating uncomplicated acute appendicitis. Participants in the study will receive one of these treatments, and their progress will be monitored to see if the appendicitis resolves without the need for surgery and does not return within a year. The study will also look at other factors such as any complications after treatment, the length of hospital stay, and the overall quality of life of the participants during the follow-up period.

The trial involves several medications, including metronidazole, glucose, ceftriaxone sodium, lidocaine hydrochloride, and ofloxacin hydrochloride. These medications are administered through infusion, which means they are given directly into the bloodstream. The study also includes a group that receives a placebo, which is a substance with no active medication, to compare the effects of the antibiotics.

Participants in the study will be monitored for a period of up to three days after their surgery. The main focus is to observe the occurrence of infections at the surgical site within 30 days after the operation. Additionally, the study will look at other factors such as the quality of life before and after surgery, the number of days without antibiotics, and the balance between antibiotic use and resistance to bacteria. The goal is to understand whether antibiotics are necessary after surgery for this type of appendicitis and to ensure the best outcomes for patients.

The purpose of the study is to compare the effectiveness of the antibiotic treatment with a placebo in managing uncomplicated acute appendicitis. Participants will be randomly assigned to one of the two groups and will not know which treatment they are receiving to ensure unbiased results. The study will monitor the participants over a period of 30 days to see if the appendicitis resolves without the need for surgery, known as an appendectomy.

Throughout the study, researchers will also observe any complications that may arise after the treatment, the length of hospital stays, and any readmissions to the hospital. Additionally, they will assess the participants’ pain levels, quality of life, and any costs associated with the treatment. The study will help determine if antibiotics are necessary for treating uncomplicated acute appendicitis or if they can be safely omitted.